Search

everythinglearnresearchcommunity

for

Search:↓

ALRN-6924 may prevent hair loss caused by chemotherapy.

Dermatologists are crucial for managing skin side effects in metastatic melanoma patients using vemurafenib and ipilimumab.

Donor lymphocyte infusions effectively treated leukemia relapse but caused vitiligo and alopecia areata.

The new nanoparticles could improve melanoma treatment by working better than current options.

Tofacitinib is somewhat effective for alopecia areata, but more research is needed on its safety and long-term effects.

Patients with acute and subacute skin lupus respond faster to belimumab than those with chronic skin lupus.

JAK inhibitors, like ruxolitinib, may effectively treat frontal fibrosing alopecia.

Teriflunomide is effective and generally safe for treating relapsing-remitting multiple sclerosis.

Skin problems are common after stem cell transplants, and early treatment by dermatologists can improve patient outcomes.

Lower doses of topotecan are safe for eyes, but higher doses may harm the retina.

A Brazilian teenager with severe hair loss had total hair regrowth with no side effects after using tofacitinib.

CGRP MAbs treatment for migraines may also improve rosacea symptoms, but more research is needed to confirm its effectiveness and safety.

Oral tofacitinib has a moderate success rate and is generally safe for treating hair loss in some patients.

A man got six skin cancers within a year after a cell transplant for leukemia but was cancer-free 32 months later; skin checks are important post-transplant.

The combination treatment showed a higher response rate but no significant survival benefits.

Some cancer and immune system drugs can cause serious side effects, including heart, lung, nerve, and organ damage, which need careful monitoring and management.

Both individual and combined treatments of tofacitinib and corticosteroids can help regrow hair in moderate-to-severe alopecia areata, but ongoing treatment may be necessary.

Monitor for early signs of myelosuppression, like hair loss, in patients on azathioprine to manage side effects.

Stem cell therapy improves healing and reduces pain in cutaneous radiation syndrome.

PRF lysates reduce inflammation in cancer cells and boost immune response in healthy oral cells.

Non-itchy rashes can indicate serious diseases like lupus.

Aldesleukin can treat certain cancers and increase HIV patient CD4+ counts but often causes severe side effects.

Deucravacitinib did not significantly improve hair regrowth in alopecia areata patients.

Abrocitinib at 100 mg and 200 mg daily may significantly improve moderate-to-severe atopic dermatitis in patients 12 years and older.

VDC-1101 shows potential as a treatment for canine cutaneous T-cell lymphoma.

JAK inhibitors are more effective and safer for treating alopecia areata than dupilumab and apremilast.

Docetaxel slightly extends prostate cancer survival but has significant side effects and high cost.

MCTD should be considered in children with recurring muscle issues, lupus-like symptoms, and edema.

Alkylating agents can kill cancer cells but may cause skin and allergic reactions.